This topic contains a solution. Click here to go to the answer

Author Question: During their initial meeting the director and set designer would A. discuss the director's ... (Read 88 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
During their initial meeting the director and set designer would
 
  A. discuss the director's concept.
  B. share concerns about technical difficulties they foresee.
  C. discuss special moments to highlight.
  D. all of the above.

Question 2

A critic is best described as a type of
 
  A. Scientist
  B. Mediator
  C. Director
  D. Paradigm



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

alexanderhamilton

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

D

Answer to Question 2

B. Critics are one of the most recognizable mediators of theatre. They wielded a lot
of power in the past.




Alygatorr01285

  • Member
  • Posts: 564
Reply 2 on: Aug 27, 2018
Wow, this really help


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The most destructive flu epidemic of all times in recorded history occurred in 1918, with approximately 20 million deaths worldwide.

Did you know?

In the United States, congenital cytomegalovirus causes one child to become disabled almost every hour. CMV is the leading preventable viral cause of development disability in newborns. These disabilities include hearing or vision loss, and cerebral palsy.

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Fungal nail infections account for up to 30% of all skin infections. They affect 5% of the general population—mostly people over the age of 70.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library